We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Transgenomic Licenses Liquid Biopsy Technology to University of Melbourne

News   Sep 18, 2015

 
Transgenomic Licenses Liquid Biopsy Technology to University of Melbourne
 
 
Advertisement
 

RELATED ARTICLES

Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

News

Indiana University School of Medicine researchers have discovered that the presence of circulating tumor DNA and circulating tumor cells in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

READ MORE

Blood-based Biomarker Can Detect and Predict Severity of Traumatic Brain Injury

News

A study from the National Institutes of Health confirms that neurofilament light chain as a blood biomarker can detect brain injury and predict recovery in multiple groups, including professional hockey players with acute or chronic concussions and clinic-based patients with mild, moderate, or severe traumatic brain injury.

READ MORE

Extracellular Vesicles Promote the Spread of Cancer in the Bloodstream

News

A new study sheds light on how extracellular vesicles, which are released by tumor cells into the bloodstream, promote the spread of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE